Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation

International Journal of Cancer

Volumn 129, Issue 8, 2011, Pages 2025-2031

  Akakura, Shin ^a   Bouchard, Rene ^a   Bshara, Wiam ^a   Morrison, Carl ^a   Gelman, Irwin H ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

AKAP12; DMBA; FAK; Gravin; papilloma; skin cancer; squamous cell carcinoma; SSeCKS; TPA

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; REGULATOR PROTEIN; SRC SUPPRESSED C KINASE SUBSTRATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SQUAMOUS PAPILLOMA; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; A KINASE ANCHOR PROTEINS; ANIMALS; CELL CYCLE PROTEINS; DISEASE PROGRESSION; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAPILLOMA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 80051995870     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25828     Document Type: Article

References (25)

1. Gelman IH,. The role of the SSeCKS/Gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci 2002; 7: d1782-d1797.
2. Gelman IH,. Metastasis suppression by SSeCKS/Gravin/AKAP12 through the spatiotemporal control of oncogenic signaling mediators. In:, Maria-Magdalena G, ed. Adaptor proteins and cancer. Kerala, India: Transworld Research Network, 2008. 83-101.
3. Lin X, Nelson PJ, Frankfort B, Tombler E, Johnson R, Gelman IH,. Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol Cell Biol 1995; 15: 2754-62.
4. Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH,. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 1996; 271: 28430-38. (Pubitemid 26374662)
5. Lin X, Gelman IH,. Re-expression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res 1997; 57: 2304-12. (Pubitemid 27247053)
6. Su B, Zheng Q, Vaughan MM, Bu Y, Gelman IH,. SSeCKS metastasis- suppressing activity in MatLyLu prostate cancer cells correlates with VEGF inhibition. Cancer Res 2006; 66: 5599-607. (Pubitemid 43927110)
7. Xia W, Unger P, Miller L, Nelson J, Gelman IH,. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 2001; 61: 5644-51. (Pubitemid 32694952)
8. Akakura S, Huang C, Nelson PJ, Foster B, Gelman IH,. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Cancer Res 2008; 68: 5096-103.
9. Gelman IH, Tombler E, Vargas J, Jr,. A role for SSeCKS, a major protein kinase C substrate with tumor suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Histochem J 2000; 32: 13-26. (Pubitemid 30204152)
10. Yoon DK, Jeong CH, Jun HO, Chun KH, Cha JH, Seo JH, Lee HY, Choi YK, Ahn BJ, Lee SK, Kim KW,. AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett 2007; 254: 111-18. (Pubitemid 47064493)
11. Pelling JC, Fischer SM, Neades R, Strawhecker J, Schweickert L,. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. Carcinogen 1987; 8: 1481-4. (Pubitemid 18045807)
12. Quintanilla M, Brown K, Ramsden M, Balmain A,. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986; 322: 78-80. (Pubitemid 16061512)
13. McLean GW, Brown K, Arbuckle MI, Wyke AW, Pikkarainen T, Ruoslahti E, Frame MC,. Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res 2001; 61: 8385-9. (Pubitemid 33131110)
14. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, Hodivala-Dilke K, Metzger D, Chambon P, Grant SG, Frame MC,. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 2004; 18: 2998-3003. (Pubitemid 39658168)
15. Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E,. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 2007; 12: 313-27. (Pubitemid 47539305)
16. Scholl FA, Dumesic PA, Barragan DI, Harada K, Charron J, Khavari PA,. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia. Cancer Res 2009; 69: 3772-8.
17. Ashman LK, Murray AW, Cook MG, Kotlarski I,. Two-stage skin carcinogenesis in sensitive and resistant mouse strains. Carcinogen 1982; 3: 99-102. (Pubitemid 12112772)
18. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH,. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogen 1993; 14: 2353-8. (Pubitemid 23335193)
19. Bangrazi C, Mouton D, Neveu T, Saran A, Covelli V, Doria G, Biozzi G,. Genetics of chemical carcinogenesis. I. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogen 1990; 11: 1711-19. (Pubitemid 20331435)
20. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T, Aizawa S,. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539-44.
21. Lin X, Nelson P, Gelman IH,. Regulation of G->S progression by the SSeCKS tumor suppressor: control of cyclin D expression and cellular compartmentalization. Mol Cell Biol 2000; 20: 7259-72.
22. Su B, Bu Y, Engelberg D, Gelman IH,. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a PKC-RAF/MEK/ERK pathway. J Biol Chem 2010; 285: 4578-86.
23. Bourcier C, Jacquel A, Hess J, Peyrottes I, Angel P, Hofman P, Auberger P, Pouyssegur J, Pages G,. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res 2006; 66: 2700-7.
24. Zhao J, Pestell R, Guan JL,. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 2002; 12: 4066-77.
25. Chandramouli A, Shi J, Feng Y, Holubec H, Shanas RM, Bhattacharyya AK, Zheng W, Nelson MA,. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Carcinogen 2007; 28: 2028-35. (Pubitemid 47500619)